Event
April 23 - 25, 2018
Pharmaceutical Compliance Congress U.S.
Global Compliance partner Brian Burke spoke on the “Global Compliance ― Emerging Markets and Third-Party Due Diligence” panel at the Pharmaceutical Compliance Congress in Washington, D.C. on April 24, 2018.
Other industry thought leaders participating on this panel included:
- David Styler
Head, Global Compliance Governance and Investigations
Takeda Pharmaceuticals
- Gildas Durand
Principal, Fraud Investigations & Dispute Services
Ernst & Young LLP
- Richard Wright
Vice President, Global Head of Compliance Audit
Teva Pharmaceuticals
Discussion topics included:
- Assess how vendors are interacting, in the marketplace, on your behalf
- Navigate the specialty marketplace and educate third parties on the complexities of marketing, selling and distributing these products
- Review strategies for effective oversight, both locally and globally
- Identify controls to minimize risk through distributors, high-risk parties and complex business transactions
- Monitor relationships with specialty pharmacies and distributors
- Ensure third parties remain compliant
- Assess what controls should be in place
- Discuss strategies for ensuring contracting compliance
- Examine sub-distributors, auditing facilities and audit provisions